Loading...
Conjugated IL17A Receptor Rabbit mAb

C56715

Conjugated IL17A Receptor Rabbit mAb

Conjugated IL17A Receptor Rabbit mAb (catalogue number C56715) is a recombinant rabbit-derived conjugated primary antibody, reactive with Human samples. It targets Interleukin-17 receptor A (IL17RA): Receptor for IL17A and IL17F, major effector cytokines of innate and adaptive immune system involved in antimicrobial host defense and maintenance of tissue integrity. Supplied as 100ul at ₪1,627.49; the final price is confirmed on your quote and the lot certificate of analysis ships with the order.

Conjugated Primary AntibodyHostRecombinant RabbitConjugateAF Dye
Host / source
Recombinant Rabbit
Reactivity
Human
Conjugate
AF Dye
UniProt ID
Q96F46
Gene
IL17RA
Target organism
Homo sapiens
Catalogue number
C56715
Brand
LABO Scientific
Storage
Store at 4˚Cin dark for 6 months

Target background

Target: Interleukin-17 receptor A (IL17RA) · Homo sapiens

Receptor for IL17A and IL17F, major effector cytokines of innate and adaptive immune system involved in antimicrobial host defense and maintenance of tissue integrity. Receptor for IL17A. Receptor for IL17F. Binds to IL17A with higher affinity than to IL17F. Binds IL17A and IL17F homodimers as part of a heterodimeric complex with IL17RC. Also binds heterodimers formed by IL17A and IL17F as part of a heterodimeric complex with IL17RC.

Subcellular location: Cell membrane

Tissue specificity: Widely expressed

Sequence length: 866 aa · 96122 Da

Protein background from UniProtKB, licensed under CC BY 4.0. Describes the target antigen, not this product.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Storage
Store at 4˚Cin dark for 6 months
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.